Chimeric mouse-human IgG1 antibody that can mediate lysis of cancer cells
- PMID: 3106970
- PMCID: PMC304886
- DOI: 10.1073/pnas.84.10.3439
Chimeric mouse-human IgG1 antibody that can mediate lysis of cancer cells
Abstract
A chimeric mouse-human antibody has been created that recognizes an antigen found on the surface of cells from many carcinomas. Immunoglobulin constant (C) domains of the mouse monoclonal antibody L6, C gamma 2a and C kappa, were substituted by the human C gamma 1 and C kappa by recombining cDNA modules encoding variable or C domains. The cDNA constructs were transfected into lymphoid cells for antibody production. The chimeric antibody and mouse L6 antibody bound to carcinoma cells with equal affinity and mediated complement-dependent cytolysis. In the presence of human effector cells, the chimeric antibody gave antibody-dependent cellular cytotoxicity at 100 times lower concentration than that needed for the mouse L6 antibody. The chimeric antibody, but not the mouse L6 antibody, is effective against a melanoma line expressing small amounts of the L6 antigen. The findings point to the usefulness of the chimeric antibody approach for obtaining agents with strong antitumor activity for possible therapeutic use in man.
Similar articles
-
Characterization of a mouse/human chimeric monoclonal antibody (C beta 1) to a principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein.AIDS Res Hum Retroviruses. 1992 Jun;8(6):1107-15. doi: 10.1089/aid.1992.8.1107. AIDS Res Hum Retroviruses. 1992. PMID: 1380258
-
Chimeric murine-human antibodies directed against folate binding receptor are efficient mediators of ovarian carcinoma cell killing.Cancer Res. 1994 May 1;54(9):2448-55. Cancer Res. 1994. PMID: 7512887
-
Chimeric anti-ganglioside GM2 antibody with antitumor activity.Cancer Res. 1994 Mar 15;54(6):1511-6. Cancer Res. 1994. PMID: 8137257
-
Binding activities and antitumor properties of a new mouse/human chimeric antibody specific for GD2 ganglioside antigen.Clin Cancer Res. 2007 Sep 15;13(18 Pt 2):5613s-5620s. doi: 10.1158/1078-0432.CCR-07-1057. Clin Cancer Res. 2007. PMID: 17875797
-
New chimeric anti-pancarcinoma monoclonal antibody with superior cytotoxicity-mediating potency.Cancer Res. 1994 Apr 1;54(7):1753-9. Cancer Res. 1994. PMID: 8137290
Cited by
-
Mouse/human chimeric monoclonal antibody in man: kinetics and immune response.Proc Natl Acad Sci U S A. 1989 Jun;86(11):4220-4. doi: 10.1073/pnas.86.11.4220. Proc Natl Acad Sci U S A. 1989. PMID: 2726771 Free PMC article. Clinical Trial.
-
A humanized antibody that binds to the interleukin 2 receptor.Proc Natl Acad Sci U S A. 1989 Dec;86(24):10029-33. doi: 10.1073/pnas.86.24.10029. Proc Natl Acad Sci U S A. 1989. PMID: 2513570 Free PMC article.
-
Mapping effector functions of a monoclonal antibody to GD3 by characterization of a mouse-human chimeric antibody.Cancer Immunol Immunother. 1994 Sep;39(3):198-204. doi: 10.1007/BF01533387. Cancer Immunol Immunother. 1994. PMID: 7522964 Free PMC article.
-
Identification of human antibody fragment clones specific for tetanus toxoid in a bacteriophage lambda immunoexpression library.Proc Natl Acad Sci U S A. 1990 Oct;87(20):8095-9. doi: 10.1073/pnas.87.20.8095. Proc Natl Acad Sci U S A. 1990. PMID: 2146680 Free PMC article.
-
Effector cell analysis of human multidrug-resistant cell killing by mouse-human chimeric antibody against P-glycoprotein.Jpn J Cancer Res. 1992 Jun;83(6):644-9. doi: 10.1111/j.1349-7006.1992.tb00138.x. Jpn J Cancer Res. 1992. PMID: 1353755 Free PMC article.
References
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources